Dr. Bykerk has an active clinical practice and works with patients with a variety of musculoskeletal and autoimmune diseases including rheumatoid arthritis, psoriatic arthritis, spondyloarthropathies, and autoimmune ophthalmic illnesses. Her work emphasizes the Hospital for Special Surgery Inflammatory Arthritis Center’s aim to ensure that patients have access to the care they need.
With a patient care focus on the importance of proper diagnosis, particularly in the early stages of inflammatory arthritis, which may prevent serious, lifelong arthritic complications. Dr. Bykerk notes that if detected and treated in its early stages, the effects of inflammatory arthritis can be greatly diminished.
"As rheumatologists, we want to see patients with new onset rheumatoid arthritis ideally as soon as possible." said Dr. Bykerk. "Patients often don’t get to us for four to six months after their symptoms have been identified. The longer they wait, the higher the chance damage will occur."
Dr. Vivian Bykerk is a member of a team of specialists at the Inflammatory Arthritis Center at Hospital for Special Surgery. The Center includes a dedicated inflammatory arthritis clinic, extensive arthritis registries, scientific studies focused on musculoskeletal and autoimmune diseases, a physician education program, and most importantly, an emphasis on providing quality health care to patients.
Dr. Bykerk brings an extensive knowledge base and experience in rheumatology. She completed a residency in Internal Medicine at Mount Sinai Hospital in Toronto, Ontario, Canada, and spent two years as a Rheumatology Fellow at McGill University, in Montreal, Quebec. Dr. Bykerk received the Senior Rheumatology Scholar Award in 1989 presented by the American College of Rheumatology for her research in lupus. She served as the Director of the Early Arthritis Program at Mount Sinai Hospital, Toronto, Ontario, Canada and comes to Hospital for Special Surgery from Brigham & Women’s Hospital, Boston, where she was in the Division of Rheumatology. She has been in rheumatology practice for over 20 years.
Senior Rheumatology Scholar Award presented by the American College of Rheumatology, 1989
Canadian Arthritis Society Fellowship, 1985-1987
Winner, Mount Sinai Hospital Clinical Research Competition, 1985
Cystic Fibrosis Research Grant, 1977
Governor's Scholarship, McMaster University, 1974
Ontario Scholarship, 1974
Industry Relationships |
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Bykerk as of March 11, 2013.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
Bykerk VP. Management of Rheumatoid Arthritis: The Newly Diagnosed Patient. Targeted Treatment of the Rheumatoid Diseases. ed. IBSN: 978-1-4160-9993-2. 2009. 17-26
Bykerk VP. Rheumatoid Arthritis. Therapeutic Choices, 5th ed. ISBN 978-1-894402-32-3. 2007. 955-971
Bykerk VP. Monitoring the Patient with Systemic Lupus Erythematosus at the Clinic and Bedside. (In Press)
International Invited Special Lectures and Presentations
Bringing the Patient to the Clinic Earlier – How to Identify Patients with Very Early Inflammatory Arthritis, European League Against Rheumatism (EULAR) London 2011, May 2011
Understanding the New Classification Criteria for the Diagnosis of Rheumatoid Arthritis; Immunology Summit, Berlin Germany 2011, February 2011
How Guidelines can be Adapted from the World Literature, Mexican-Canadian Rheumatology Association Annual Meeting, Cancun Mexico, February 2011
How to Manage Early Rheumatoid Arthritis, Mexican-Canadian Rheumatology Association Annual meeting, Cancun Mexico, February 2011
How to Make a Diagnosis of Rheumatoid Arthritis Earlier (European League Against Rheumatology Annual Meeting), June 2010
Practical Issues in Making the Diagnosis of Rheumatology (EULAR Fellows Lecture), June 2010
Controversies in Treating Patients with Early RA – Impact of Recent Clinical Trials. Brigham & Women’s Annual Centacor Arthritis Day, Harvard University, ec. 2009
What the Early Arthritis Cohorts have Taught Us – Presented at Rheumatology Grand Rounds, Cedar Sinai Hospital, Los Angeles, Nov. 2009
Treating the patient with Early Arthritis – a Workshop. Promise & Progress meeting. Amsterdam, March 2009
Tocilizumab investigator Meeting, Budapest. An overview of clinical efficacy and safety data on Tocilizumab, Sept. 2008
Oral Podium Presentations of Abstracts at International Meetings:
The Revised 2010 ACR/EULAR Diagnostic Criteria for Rheumatoid Arthritis Identify Many More Patients Who Are Eligible for Treatment and for Clinical Trials. American College of Rheumatology, Atlanta, Nov. 2010
Care Gap in Early Inflammatory Arthritis Patients with a High Fracture Risk Identified Using the FRAX® Tool Podium Presentation American College of Rheumatology Meeting, Philadelphia, FRAX, Nov. 2009
European League Against Rheumatism (EULAR) Symposium, Barcelona - Proportion of patients reaching remission and sustained remission in a real world cohort of patient with early RA treated with initial DMARD therapy, June 2007
Podium Presentation American College of Rheumatology Meeting, Boston– A High Proportion of patients reaching sustained remission in an early arthritis cohort," Nov. 2007
Dr. Bykerk is currently developing a clinical research program in early rheumatoid arthritis in collaboration with the Inflammatory Arthritis Center. This research program will focus on early inflammatory arthritis, identifying important questions, and addressing them through the use of Hospital for Special Surgery’s research registries. She is also the director of the Consortion of Early Arthritis Cohort Studies; a group of observational research studies in early RA in North America.
Dr. Bykerk is also involved in the planning of a clinical research program in Perioperative Medicine.
© Hospital for Special Surgery. 535 East 70th Street, New York, NY 10021